MTOR and metabolic disease: Metabolic disorders induce the expression of nutritionally and metabolically related growth factors, such as leptin, insulin, and insulin-like growth factor 1 (IGF-1), which activate mechanistic target of rapamycin (mTOR) signaling in immune cells, thereby affecting systemic and intracellular immune metabolism, and consequently inflammation.